nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Acetylsalicylic acid—coronary artery disease	0.341	1	CpDpCtD
Sumatriptan—HTR1B—Penbutolol—coronary artery disease	0.0291	0.0655	CbGbCtD
Sumatriptan—SLCO1B1—Gemfibrozil—coronary artery disease	0.0248	0.0557	CbGbCtD
Sumatriptan—SLCO1B1—Olmesartan—coronary artery disease	0.0235	0.0528	CbGbCtD
Sumatriptan—SLCO1A2—Enalapril—coronary artery disease	0.0189	0.0424	CbGbCtD
Sumatriptan—SLCO1B1—Pitavastatin—coronary artery disease	0.0188	0.0422	CbGbCtD
Sumatriptan—SLCO1B1—Valsartan—coronary artery disease	0.0183	0.0411	CbGbCtD
Sumatriptan—HTR1A—Penbutolol—coronary artery disease	0.0182	0.041	CbGbCtD
Sumatriptan—ABCG2—Pitavastatin—coronary artery disease	0.0149	0.0336	CbGbCtD
Sumatriptan—ABCG2—Telmisartan—coronary artery disease	0.0149	0.0336	CbGbCtD
Sumatriptan—SLCO1A2—Rosuvastatin—coronary artery disease	0.0147	0.033	CbGbCtD
Sumatriptan—SLCO1B1—Rosuvastatin—coronary artery disease	0.0138	0.0311	CbGbCtD
Sumatriptan—SLCO1B1—Ezetimibe—coronary artery disease	0.0138	0.0311	CbGbCtD
Sumatriptan—SLCO1A2—Simvastatin—coronary artery disease	0.0136	0.0307	CbGbCtD
Sumatriptan—SLCO1A2—Lovastatin—coronary artery disease	0.0134	0.03	CbGbCtD
Sumatriptan—SLCO1A2—Pravastatin—coronary artery disease	0.0134	0.03	CbGbCtD
Sumatriptan—SLCO1B1—Simvastatin—coronary artery disease	0.0129	0.0289	CbGbCtD
Sumatriptan—SLCO1B1—Pravastatin—coronary artery disease	0.0126	0.0283	CbGbCtD
Sumatriptan—SLCO1B1—Lovastatin—coronary artery disease	0.0126	0.0283	CbGbCtD
Sumatriptan—SLCO1A2—Atorvastatin—coronary artery disease	0.0122	0.0273	CbGbCtD
Sumatriptan—SLCO1B1—Atorvastatin—coronary artery disease	0.0115	0.0258	CbGbCtD
Sumatriptan—ABCG2—Ezetimibe—coronary artery disease	0.011	0.0247	CbGbCtD
Sumatriptan—ABCG2—Rosuvastatin—coronary artery disease	0.011	0.0247	CbGbCtD
Sumatriptan—SLCO1B1—Losartan—coronary artery disease	0.0105	0.0236	CbGbCtD
Sumatriptan—ABCG2—Pravastatin—coronary artery disease	0.01	0.0225	CbGbCtD
Sumatriptan—ABCB1—Ticagrelor—coronary artery disease	0.00996	0.0224	CbGbCtD
Sumatriptan—ABCB1—Perindopril—coronary artery disease	0.00616	0.0138	CbGbCtD
Sumatriptan—ABCB1—Clopidogrel—coronary artery disease	0.00616	0.0138	CbGbCtD
Sumatriptan—ABCB1—Pitavastatin—coronary artery disease	0.00538	0.0121	CbGbCtD
Sumatriptan—ABCB1—Telmisartan—coronary artery disease	0.00538	0.0121	CbGbCtD
Sumatriptan—ABCB1—Enalapril—coronary artery disease	0.0051	0.0115	CbGbCtD
Sumatriptan—ABCB1—Lisinopril—coronary artery disease	0.0051	0.0115	CbGbCtD
Sumatriptan—ABCB1—Timolol—coronary artery disease	0.00434	0.00975	CbGbCtD
Sumatriptan—ABCB1—Ezetimibe—coronary artery disease	0.00397	0.00892	CbGbCtD
Sumatriptan—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00387	0.00869	CbGbCtD
Sumatriptan—ABCB1—Captopril—coronary artery disease	0.00382	0.00859	CbGbCtD
Sumatriptan—ABCB1—Simvastatin—coronary artery disease	0.00369	0.00829	CbGbCtD
Sumatriptan—ABCB1—Pravastatin—coronary artery disease	0.00361	0.00811	CbGbCtD
Sumatriptan—ABCB1—Lovastatin—coronary artery disease	0.00361	0.00811	CbGbCtD
Sumatriptan—ABCB1—Atorvastatin—coronary artery disease	0.00329	0.00739	CbGbCtD
Sumatriptan—ABCB1—Losartan—coronary artery disease	0.00301	0.00676	CbGbCtD
Sumatriptan—Melatonin—CALR—coronary artery disease	0.0011	0.502	CrCbGaD
Sumatriptan—HTR3A—vagus nerve—coronary artery disease	0.000986	0.333	CbGeAlD
Sumatriptan—HTR1B—artery—coronary artery disease	0.000326	0.11	CbGeAlD
Sumatriptan—HTR1D—artery—coronary artery disease	0.000315	0.106	CbGeAlD
Sumatriptan—Eletriptan—HTR7—coronary artery disease	0.000243	0.11	CrCbGaD
Sumatriptan—Melatonin—MPO—coronary artery disease	0.000217	0.0985	CrCbGaD
Sumatriptan—Almotriptan—CYP2C19—coronary artery disease	0.000193	0.0878	CrCbGaD
Sumatriptan—Melatonin—ESR1—coronary artery disease	0.000163	0.0739	CrCbGaD
Sumatriptan—Eletriptan—CYP2C19—coronary artery disease	0.000151	0.0684	CrCbGaD
Sumatriptan—MAOA—cardiac ventricle—coronary artery disease	0.000135	0.0455	CbGeAlD
Sumatriptan—Melatonin—CYP2C19—coronary artery disease	0.000131	0.0593	CrCbGaD
Sumatriptan—MAOA—myocardium—coronary artery disease	0.000127	0.0428	CbGeAlD
Sumatriptan—HTR1B—cardiovascular system—coronary artery disease	0.000113	0.0382	CbGeAlD
Sumatriptan—HTR1D—cardiovascular system—coronary artery disease	0.00011	0.037	CbGeAlD
Sumatriptan—HTR3A—blood—coronary artery disease	0.000107	0.036	CbGeAlD
Sumatriptan—SLCO1B1—blood—coronary artery disease	0.000103	0.0349	CbGeAlD
Sumatriptan—HTR1A—cardiovascular system—coronary artery disease	9.13e-05	0.0308	CbGeAlD
Sumatriptan—MAOA—heart—coronary artery disease	8.84e-05	0.0299	CbGeAlD
Sumatriptan—MAOA—cardiovascular system—coronary artery disease	8.34e-05	0.0282	CbGeAlD
Sumatriptan—ABCG2—heart—coronary artery disease	7.66e-05	0.0259	CbGeAlD
Sumatriptan—MAOA—cardiac atrium—coronary artery disease	7.56e-05	0.0255	CbGeAlD
Sumatriptan—MAOA—blood—coronary artery disease	6.6e-05	0.0223	CbGeAlD
Sumatriptan—ABCG2—blood—coronary artery disease	5.72e-05	0.0193	CbGeAlD
Sumatriptan—ABCB1—heart—coronary artery disease	3.78e-05	0.0128	CbGeAlD
Sumatriptan—ABCB1—cardiovascular system—coronary artery disease	3.57e-05	0.012	CbGeAlD
Sumatriptan—Decreased appetite—Losartan—coronary artery disease	2.82e-05	0.000202	CcSEcCtD
Sumatriptan—ABCB1—blood—coronary artery disease	2.82e-05	0.00952	CbGeAlD
Sumatriptan—Abdominal pain—Captopril—coronary artery disease	2.82e-05	0.000201	CcSEcCtD
Sumatriptan—Body temperature increased—Captopril—coronary artery disease	2.82e-05	0.000201	CcSEcCtD
Sumatriptan—Dizziness—Simvastatin—coronary artery disease	2.81e-05	0.000201	CcSEcCtD
Sumatriptan—Rash—Ezetimibe—coronary artery disease	2.81e-05	0.000201	CcSEcCtD
Sumatriptan—Dermatitis—Ezetimibe—coronary artery disease	2.81e-05	0.000201	CcSEcCtD
Sumatriptan—Confusional state—Ramipril—coronary artery disease	2.81e-05	0.000201	CcSEcCtD
Sumatriptan—Discomfort—Timolol—coronary artery disease	2.81e-05	0.0002	CcSEcCtD
Sumatriptan—Asthenia—Niacin—coronary artery disease	2.8e-05	0.0002	CcSEcCtD
Sumatriptan—Fatigue—Losartan—coronary artery disease	2.8e-05	0.0002	CcSEcCtD
Sumatriptan—Headache—Ezetimibe—coronary artery disease	2.79e-05	0.0002	CcSEcCtD
Sumatriptan—Malaise—Lisinopril—coronary artery disease	2.79e-05	0.000199	CcSEcCtD
Sumatriptan—Anaphylactic shock—Ramipril—coronary artery disease	2.78e-05	0.000199	CcSEcCtD
Sumatriptan—Oedema—Ramipril—coronary artery disease	2.78e-05	0.000199	CcSEcCtD
Sumatriptan—Vertigo—Lisinopril—coronary artery disease	2.78e-05	0.000199	CcSEcCtD
Sumatriptan—Dry mouth—Timolol—coronary artery disease	2.78e-05	0.000198	CcSEcCtD
Sumatriptan—Pain—Losartan—coronary artery disease	2.78e-05	0.000198	CcSEcCtD
Sumatriptan—Constipation—Losartan—coronary artery disease	2.78e-05	0.000198	CcSEcCtD
Sumatriptan—Syncope—Lisinopril—coronary artery disease	2.78e-05	0.000198	CcSEcCtD
Sumatriptan—Vomiting—Eplerenone—coronary artery disease	2.77e-05	0.000198	CcSEcCtD
Sumatriptan—Feeling abnormal—Furosemide—coronary artery disease	2.77e-05	0.000198	CcSEcCtD
Sumatriptan—Nausea—Fenofibrate—coronary artery disease	2.77e-05	0.000198	CcSEcCtD
Sumatriptan—Pruritus—Niacin—coronary artery disease	2.76e-05	0.000197	CcSEcCtD
Sumatriptan—Asthenia—Pravastatin—coronary artery disease	2.76e-05	0.000197	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Furosemide—coronary artery disease	2.75e-05	0.000197	CcSEcCtD
Sumatriptan—Rash—Eplerenone—coronary artery disease	2.75e-05	0.000197	CcSEcCtD
Sumatriptan—Urticaria—Perindopril—coronary artery disease	2.75e-05	0.000196	CcSEcCtD
Sumatriptan—Hypersensitivity—Trandolapril—coronary artery disease	2.75e-05	0.000196	CcSEcCtD
Sumatriptan—Dermatitis—Eplerenone—coronary artery disease	2.75e-05	0.000196	CcSEcCtD
Sumatriptan—Diarrhoea—Valsartan—coronary artery disease	2.75e-05	0.000196	CcSEcCtD
Sumatriptan—Confusional state—Timolol—coronary artery disease	2.75e-05	0.000196	CcSEcCtD
Sumatriptan—Shock—Ramipril—coronary artery disease	2.74e-05	0.000196	CcSEcCtD
Sumatriptan—Hypersensitivity—Enalapril—coronary artery disease	2.74e-05	0.000196	CcSEcCtD
Sumatriptan—Body temperature increased—Perindopril—coronary artery disease	2.74e-05	0.000196	CcSEcCtD
Sumatriptan—Abdominal pain—Perindopril—coronary artery disease	2.74e-05	0.000196	CcSEcCtD
Sumatriptan—Palpitations—Lisinopril—coronary artery disease	2.73e-05	0.000195	CcSEcCtD
Sumatriptan—Diarrhoea—Olmesartan—coronary artery disease	2.73e-05	0.000195	CcSEcCtD
Sumatriptan—Headache—Eplerenone—coronary artery disease	2.73e-05	0.000195	CcSEcCtD
Sumatriptan—Nervous system disorder—Ramipril—coronary artery disease	2.73e-05	0.000195	CcSEcCtD
Sumatriptan—Thrombocytopenia—Ramipril—coronary artery disease	2.73e-05	0.000195	CcSEcCtD
Sumatriptan—Anaphylactic shock—Timolol—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Oedema—Timolol—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Pruritus—Pravastatin—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Loss of consciousness—Lisinopril—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Nausea—Clopidogrel—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Tachycardia—Ramipril—coronary artery disease	2.72e-05	0.000194	CcSEcCtD
Sumatriptan—Skin disorder—Ramipril—coronary artery disease	2.71e-05	0.000193	CcSEcCtD
Sumatriptan—Infection—Timolol—coronary artery disease	2.7e-05	0.000193	CcSEcCtD
Sumatriptan—Vomiting—Simvastatin—coronary artery disease	2.7e-05	0.000193	CcSEcCtD
Sumatriptan—Hypersensitivity—Telmisartan—coronary artery disease	2.7e-05	0.000193	CcSEcCtD
Sumatriptan—Cough—Lisinopril—coronary artery disease	2.7e-05	0.000193	CcSEcCtD
Sumatriptan—Nausea—Lovastatin—coronary artery disease	2.7e-05	0.000193	CcSEcCtD
Sumatriptan—Hyperhidrosis—Ramipril—coronary artery disease	2.69e-05	0.000192	CcSEcCtD
Sumatriptan—Rash—Simvastatin—coronary artery disease	2.68e-05	0.000191	CcSEcCtD
Sumatriptan—Dermatitis—Simvastatin—coronary artery disease	2.68e-05	0.000191	CcSEcCtD
Sumatriptan—Asthenia—Trandolapril—coronary artery disease	2.68e-05	0.000191	CcSEcCtD
Sumatriptan—Shock—Timolol—coronary artery disease	2.68e-05	0.000191	CcSEcCtD
Sumatriptan—Feeling abnormal—Losartan—coronary artery disease	2.68e-05	0.000191	CcSEcCtD
Sumatriptan—Urticaria—Furosemide—coronary artery disease	2.67e-05	0.000191	CcSEcCtD
Sumatriptan—Diarrhoea—Niacin—coronary artery disease	2.67e-05	0.000191	CcSEcCtD
Sumatriptan—Nervous system disorder—Timolol—coronary artery disease	2.67e-05	0.000191	CcSEcCtD
Sumatriptan—Asthenia—Enalapril—coronary artery disease	2.67e-05	0.000191	CcSEcCtD
Sumatriptan—Headache—Simvastatin—coronary artery disease	2.66e-05	0.00019	CcSEcCtD
Sumatriptan—Body temperature increased—Furosemide—coronary artery disease	2.66e-05	0.00019	CcSEcCtD
Sumatriptan—Abdominal pain—Furosemide—coronary artery disease	2.66e-05	0.00019	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Losartan—coronary artery disease	2.66e-05	0.00019	CcSEcCtD
Sumatriptan—Dizziness—Valsartan—coronary artery disease	2.66e-05	0.00019	CcSEcCtD
Sumatriptan—Nausea—Ezetimibe—coronary artery disease	2.65e-05	0.000189	CcSEcCtD
Sumatriptan—Skin disorder—Timolol—coronary artery disease	2.64e-05	0.000189	CcSEcCtD
Sumatriptan—Dizziness—Olmesartan—coronary artery disease	2.64e-05	0.000189	CcSEcCtD
Sumatriptan—Pruritus—Trandolapril—coronary artery disease	2.64e-05	0.000189	CcSEcCtD
Sumatriptan—Myalgia—Lisinopril—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Chest pain—Lisinopril—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Arthralgia—Lisinopril—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Hyperhidrosis—Timolol—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Asthenia—Telmisartan—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Pruritus—Enalapril—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Diarrhoea—Pravastatin—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Anxiety—Lisinopril—coronary artery disease	2.63e-05	0.000188	CcSEcCtD
Sumatriptan—Discomfort—Lisinopril—coronary artery disease	2.6e-05	0.000186	CcSEcCtD
Sumatriptan—Hypotension—Ramipril—coronary artery disease	2.6e-05	0.000186	CcSEcCtD
Sumatriptan—Pruritus—Telmisartan—coronary artery disease	2.59e-05	0.000185	CcSEcCtD
Sumatriptan—Nausea—Eplerenone—coronary artery disease	2.59e-05	0.000185	CcSEcCtD
Sumatriptan—Dizziness—Niacin—coronary artery disease	2.58e-05	0.000184	CcSEcCtD
Sumatriptan—Urticaria—Losartan—coronary artery disease	2.58e-05	0.000184	CcSEcCtD
Sumatriptan—Dry mouth—Lisinopril—coronary artery disease	2.58e-05	0.000184	CcSEcCtD
Sumatriptan—Abdominal pain—Losartan—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Sumatriptan—Body temperature increased—Losartan—coronary artery disease	2.57e-05	0.000183	CcSEcCtD
Sumatriptan—Asthenia—Captopril—coronary artery disease	2.56e-05	0.000183	CcSEcCtD
Sumatriptan—Diarrhoea—Trandolapril—coronary artery disease	2.55e-05	0.000182	CcSEcCtD
Sumatriptan—Vomiting—Valsartan—coronary artery disease	2.55e-05	0.000182	CcSEcCtD
Sumatriptan—Confusional state—Lisinopril—coronary artery disease	2.55e-05	0.000182	CcSEcCtD
Sumatriptan—Diarrhoea—Enalapril—coronary artery disease	2.54e-05	0.000182	CcSEcCtD
Sumatriptan—Hypotension—Timolol—coronary artery disease	2.54e-05	0.000182	CcSEcCtD
Sumatriptan—Dizziness—Pravastatin—coronary artery disease	2.54e-05	0.000182	CcSEcCtD
Sumatriptan—Vomiting—Olmesartan—coronary artery disease	2.54e-05	0.000181	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.54e-05	0.000181	CcSEcCtD
Sumatriptan—Rash—Valsartan—coronary artery disease	2.53e-05	0.000181	CcSEcCtD
Sumatriptan—Dermatitis—Valsartan—coronary artery disease	2.53e-05	0.000181	CcSEcCtD
Sumatriptan—Nausea—Simvastatin—coronary artery disease	2.53e-05	0.00018	CcSEcCtD
Sumatriptan—Anaphylactic shock—Lisinopril—coronary artery disease	2.53e-05	0.00018	CcSEcCtD
Sumatriptan—Oedema—Lisinopril—coronary artery disease	2.53e-05	0.00018	CcSEcCtD
Sumatriptan—Pruritus—Captopril—coronary artery disease	2.52e-05	0.00018	CcSEcCtD
Sumatriptan—Rash—Olmesartan—coronary artery disease	2.52e-05	0.00018	CcSEcCtD
Sumatriptan—Dermatitis—Olmesartan—coronary artery disease	2.52e-05	0.00018	CcSEcCtD
Sumatriptan—Headache—Valsartan—coronary artery disease	2.52e-05	0.00018	CcSEcCtD
Sumatriptan—Diarrhoea—Telmisartan—coronary artery disease	2.51e-05	0.000179	CcSEcCtD
Sumatriptan—Infection—Lisinopril—coronary artery disease	2.51e-05	0.000179	CcSEcCtD
Sumatriptan—Headache—Olmesartan—coronary artery disease	2.5e-05	0.000179	CcSEcCtD
Sumatriptan—Paraesthesia—Ramipril—coronary artery disease	2.5e-05	0.000179	CcSEcCtD
Sumatriptan—Shock—Lisinopril—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Asthenia—Perindopril—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Dyspnoea—Ramipril—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Vomiting—Niacin—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Timolol—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Hypersensitivity—Furosemide—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Somnolence—Ramipril—coronary artery disease	2.48e-05	0.000177	CcSEcCtD
Sumatriptan—Thrombocytopenia—Lisinopril—coronary artery disease	2.47e-05	0.000177	CcSEcCtD
Sumatriptan—Dizziness—Trandolapril—coronary artery disease	2.47e-05	0.000176	CcSEcCtD
Sumatriptan—Tachycardia—Lisinopril—coronary artery disease	2.46e-05	0.000176	CcSEcCtD
Sumatriptan—Rash—Niacin—coronary artery disease	2.46e-05	0.000176	CcSEcCtD
Sumatriptan—Dermatitis—Niacin—coronary artery disease	2.46e-05	0.000176	CcSEcCtD
Sumatriptan—Dizziness—Enalapril—coronary artery disease	2.46e-05	0.000176	CcSEcCtD
Sumatriptan—Skin disorder—Lisinopril—coronary artery disease	2.45e-05	0.000175	CcSEcCtD
Sumatriptan—Pruritus—Perindopril—coronary artery disease	2.45e-05	0.000175	CcSEcCtD
Sumatriptan—Headache—Niacin—coronary artery disease	2.45e-05	0.000175	CcSEcCtD
Sumatriptan—Paraesthesia—Timolol—coronary artery disease	2.44e-05	0.000175	CcSEcCtD
Sumatriptan—Vomiting—Pravastatin—coronary artery disease	2.44e-05	0.000175	CcSEcCtD
Sumatriptan—Hyperhidrosis—Lisinopril—coronary artery disease	2.44e-05	0.000174	CcSEcCtD
Sumatriptan—Diarrhoea—Captopril—coronary artery disease	2.44e-05	0.000174	CcSEcCtD
Sumatriptan—Dyspnoea—Timolol—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Sumatriptan—Dizziness—Telmisartan—coronary artery disease	2.43e-05	0.000173	CcSEcCtD
Sumatriptan—Rash—Pravastatin—coronary artery disease	2.42e-05	0.000173	CcSEcCtD
Sumatriptan—Dermatitis—Pravastatin—coronary artery disease	2.42e-05	0.000173	CcSEcCtD
Sumatriptan—Decreased appetite—Ramipril—coronary artery disease	2.42e-05	0.000173	CcSEcCtD
Sumatriptan—Somnolence—Timolol—coronary artery disease	2.42e-05	0.000173	CcSEcCtD
Sumatriptan—Asthenia—Furosemide—coronary artery disease	2.42e-05	0.000172	CcSEcCtD
Sumatriptan—Headache—Pravastatin—coronary artery disease	2.41e-05	0.000172	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Ramipril—coronary artery disease	2.4e-05	0.000172	CcSEcCtD
Sumatriptan—Fatigue—Ramipril—coronary artery disease	2.4e-05	0.000171	CcSEcCtD
Sumatriptan—Hypersensitivity—Losartan—coronary artery disease	2.39e-05	0.000171	CcSEcCtD
Sumatriptan—Nausea—Valsartan—coronary artery disease	2.39e-05	0.00017	CcSEcCtD
Sumatriptan—Pruritus—Furosemide—coronary artery disease	2.38e-05	0.00017	CcSEcCtD
Sumatriptan—Constipation—Ramipril—coronary artery disease	2.38e-05	0.00017	CcSEcCtD
Sumatriptan—Nausea—Olmesartan—coronary artery disease	2.37e-05	0.00017	CcSEcCtD
Sumatriptan—Vomiting—Trandolapril—coronary artery disease	2.37e-05	0.00017	CcSEcCtD
Sumatriptan—Diarrhoea—Perindopril—coronary artery disease	2.37e-05	0.000169	CcSEcCtD
Sumatriptan—Decreased appetite—Timolol—coronary artery disease	2.37e-05	0.000169	CcSEcCtD
Sumatriptan—Vomiting—Enalapril—coronary artery disease	2.36e-05	0.000169	CcSEcCtD
Sumatriptan—Hypotension—Lisinopril—coronary artery disease	2.36e-05	0.000169	CcSEcCtD
Sumatriptan—Dizziness—Captopril—coronary artery disease	2.36e-05	0.000168	CcSEcCtD
Sumatriptan—Rash—Trandolapril—coronary artery disease	2.35e-05	0.000168	CcSEcCtD
Sumatriptan—Dermatitis—Trandolapril—coronary artery disease	2.35e-05	0.000168	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Timolol—coronary artery disease	2.35e-05	0.000168	CcSEcCtD
Sumatriptan—Fatigue—Timolol—coronary artery disease	2.35e-05	0.000168	CcSEcCtD
Sumatriptan—Rash—Enalapril—coronary artery disease	2.34e-05	0.000167	CcSEcCtD
Sumatriptan—Dermatitis—Enalapril—coronary artery disease	2.34e-05	0.000167	CcSEcCtD
Sumatriptan—Headache—Trandolapril—coronary artery disease	2.34e-05	0.000167	CcSEcCtD
Sumatriptan—Vomiting—Telmisartan—coronary artery disease	2.33e-05	0.000167	CcSEcCtD
Sumatriptan—Asthenia—Losartan—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Sumatriptan—Headache—Enalapril—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Sumatriptan—Pain—Timolol—coronary artery disease	2.33e-05	0.000166	CcSEcCtD
Sumatriptan—Nausea—Niacin—coronary artery disease	2.32e-05	0.000166	CcSEcCtD
Sumatriptan—Rash—Telmisartan—coronary artery disease	2.31e-05	0.000165	CcSEcCtD
Sumatriptan—Dermatitis—Telmisartan—coronary artery disease	2.31e-05	0.000165	CcSEcCtD
Sumatriptan—Diarrhoea—Furosemide—coronary artery disease	2.3e-05	0.000164	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.3e-05	0.000164	CcSEcCtD
Sumatriptan—Pruritus—Losartan—coronary artery disease	2.3e-05	0.000164	CcSEcCtD
Sumatriptan—Headache—Telmisartan—coronary artery disease	2.3e-05	0.000164	CcSEcCtD
Sumatriptan—Feeling abnormal—Ramipril—coronary artery disease	2.29e-05	0.000164	CcSEcCtD
Sumatriptan—Dizziness—Perindopril—coronary artery disease	2.29e-05	0.000164	CcSEcCtD
Sumatriptan—Nausea—Pravastatin—coronary artery disease	2.28e-05	0.000163	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Ramipril—coronary artery disease	2.28e-05	0.000163	CcSEcCtD
Sumatriptan—Paraesthesia—Lisinopril—coronary artery disease	2.27e-05	0.000162	CcSEcCtD
Sumatriptan—Vomiting—Captopril—coronary artery disease	2.27e-05	0.000162	CcSEcCtD
Sumatriptan—Dyspnoea—Lisinopril—coronary artery disease	2.25e-05	0.000161	CcSEcCtD
Sumatriptan—Rash—Captopril—coronary artery disease	2.25e-05	0.000161	CcSEcCtD
Sumatriptan—Dermatitis—Captopril—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Sumatriptan—Somnolence—Lisinopril—coronary artery disease	2.25e-05	0.00016	CcSEcCtD
Sumatriptan—Feeling abnormal—Timolol—coronary artery disease	2.24e-05	0.00016	CcSEcCtD
Sumatriptan—Headache—Captopril—coronary artery disease	2.23e-05	0.00016	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Timolol—coronary artery disease	2.23e-05	0.000159	CcSEcCtD
Sumatriptan—Dizziness—Furosemide—coronary artery disease	2.23e-05	0.000159	CcSEcCtD
Sumatriptan—Diarrhoea—Losartan—coronary artery disease	2.22e-05	0.000159	CcSEcCtD
Sumatriptan—Nausea—Trandolapril—coronary artery disease	2.22e-05	0.000158	CcSEcCtD
Sumatriptan—Urticaria—Ramipril—coronary artery disease	2.21e-05	0.000158	CcSEcCtD
Sumatriptan—Nausea—Enalapril—coronary artery disease	2.21e-05	0.000158	CcSEcCtD
Sumatriptan—Vomiting—Perindopril—coronary artery disease	2.2e-05	0.000157	CcSEcCtD
Sumatriptan—Abdominal pain—Ramipril—coronary artery disease	2.2e-05	0.000157	CcSEcCtD
Sumatriptan—Body temperature increased—Ramipril—coronary artery disease	2.2e-05	0.000157	CcSEcCtD
Sumatriptan—Decreased appetite—Lisinopril—coronary artery disease	2.2e-05	0.000157	CcSEcCtD
Sumatriptan—Rash—Perindopril—coronary artery disease	2.18e-05	0.000156	CcSEcCtD
Sumatriptan—Dermatitis—Perindopril—coronary artery disease	2.18e-05	0.000156	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.18e-05	0.000156	CcSEcCtD
Sumatriptan—Nausea—Telmisartan—coronary artery disease	2.18e-05	0.000156	CcSEcCtD
Sumatriptan—Fatigue—Lisinopril—coronary artery disease	2.18e-05	0.000156	CcSEcCtD
Sumatriptan—Headache—Perindopril—coronary artery disease	2.17e-05	0.000155	CcSEcCtD
Sumatriptan—Urticaria—Timolol—coronary artery disease	2.16e-05	0.000154	CcSEcCtD
Sumatriptan—Pain—Lisinopril—coronary artery disease	2.16e-05	0.000154	CcSEcCtD
Sumatriptan—Constipation—Lisinopril—coronary artery disease	2.16e-05	0.000154	CcSEcCtD
Sumatriptan—Abdominal pain—Timolol—coronary artery disease	2.15e-05	0.000154	CcSEcCtD
Sumatriptan—Body temperature increased—Timolol—coronary artery disease	2.15e-05	0.000154	CcSEcCtD
Sumatriptan—Dizziness—Losartan—coronary artery disease	2.15e-05	0.000153	CcSEcCtD
Sumatriptan—Vomiting—Furosemide—coronary artery disease	2.14e-05	0.000153	CcSEcCtD
Sumatriptan—Rash—Furosemide—coronary artery disease	2.12e-05	0.000152	CcSEcCtD
Sumatriptan—Dermatitis—Furosemide—coronary artery disease	2.12e-05	0.000151	CcSEcCtD
Sumatriptan—Nausea—Captopril—coronary artery disease	2.12e-05	0.000151	CcSEcCtD
Sumatriptan—Headache—Furosemide—coronary artery disease	2.11e-05	0.000151	CcSEcCtD
Sumatriptan—Feeling abnormal—Lisinopril—coronary artery disease	2.08e-05	0.000149	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Lisinopril—coronary artery disease	2.07e-05	0.000148	CcSEcCtD
Sumatriptan—Vomiting—Losartan—coronary artery disease	2.07e-05	0.000147	CcSEcCtD
Sumatriptan—Nausea—Perindopril—coronary artery disease	2.06e-05	0.000147	CcSEcCtD
Sumatriptan—Hypersensitivity—Ramipril—coronary artery disease	2.05e-05	0.000147	CcSEcCtD
Sumatriptan—Rash—Losartan—coronary artery disease	2.05e-05	0.000146	CcSEcCtD
Sumatriptan—Dermatitis—Losartan—coronary artery disease	2.05e-05	0.000146	CcSEcCtD
Sumatriptan—Headache—Losartan—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Sumatriptan—Urticaria—Lisinopril—coronary artery disease	2.01e-05	0.000143	CcSEcCtD
Sumatriptan—Hypersensitivity—Timolol—coronary artery disease	2.01e-05	0.000143	CcSEcCtD
Sumatriptan—Nausea—Furosemide—coronary artery disease	2e-05	0.000143	CcSEcCtD
Sumatriptan—Asthenia—Ramipril—coronary artery disease	2e-05	0.000143	CcSEcCtD
Sumatriptan—Abdominal pain—Lisinopril—coronary artery disease	2e-05	0.000143	CcSEcCtD
Sumatriptan—Body temperature increased—Lisinopril—coronary artery disease	2e-05	0.000143	CcSEcCtD
Sumatriptan—Pruritus—Ramipril—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Sumatriptan—Asthenia—Timolol—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Sumatriptan—Nausea—Losartan—coronary artery disease	1.93e-05	0.000138	CcSEcCtD
Sumatriptan—Pruritus—Timolol—coronary artery disease	1.93e-05	0.000138	CcSEcCtD
Sumatriptan—Diarrhoea—Ramipril—coronary artery disease	1.91e-05	0.000136	CcSEcCtD
Sumatriptan—Diarrhoea—Timolol—coronary artery disease	1.86e-05	0.000133	CcSEcCtD
Sumatriptan—Hypersensitivity—Lisinopril—coronary artery disease	1.86e-05	0.000133	CcSEcCtD
Sumatriptan—Dizziness—Ramipril—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Sumatriptan—Asthenia—Lisinopril—coronary artery disease	1.81e-05	0.000129	CcSEcCtD
Sumatriptan—Dizziness—Timolol—coronary artery disease	1.8e-05	0.000129	CcSEcCtD
Sumatriptan—Pruritus—Lisinopril—coronary artery disease	1.79e-05	0.000128	CcSEcCtD
Sumatriptan—Vomiting—Ramipril—coronary artery disease	1.77e-05	0.000126	CcSEcCtD
Sumatriptan—Rash—Ramipril—coronary artery disease	1.76e-05	0.000125	CcSEcCtD
Sumatriptan—Dermatitis—Ramipril—coronary artery disease	1.75e-05	0.000125	CcSEcCtD
Sumatriptan—Headache—Ramipril—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Sumatriptan—Vomiting—Timolol—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Sumatriptan—Diarrhoea—Lisinopril—coronary artery disease	1.73e-05	0.000123	CcSEcCtD
Sumatriptan—Rash—Timolol—coronary artery disease	1.72e-05	0.000123	CcSEcCtD
Sumatriptan—Dermatitis—Timolol—coronary artery disease	1.71e-05	0.000122	CcSEcCtD
Sumatriptan—Headache—Timolol—coronary artery disease	1.71e-05	0.000122	CcSEcCtD
Sumatriptan—Dizziness—Lisinopril—coronary artery disease	1.67e-05	0.000119	CcSEcCtD
Sumatriptan—Nausea—Ramipril—coronary artery disease	1.65e-05	0.000118	CcSEcCtD
Sumatriptan—Nausea—Timolol—coronary artery disease	1.62e-05	0.000115	CcSEcCtD
Sumatriptan—Vomiting—Lisinopril—coronary artery disease	1.61e-05	0.000115	CcSEcCtD
Sumatriptan—Rash—Lisinopril—coronary artery disease	1.59e-05	0.000114	CcSEcCtD
Sumatriptan—Dermatitis—Lisinopril—coronary artery disease	1.59e-05	0.000114	CcSEcCtD
Sumatriptan—Headache—Lisinopril—coronary artery disease	1.58e-05	0.000113	CcSEcCtD
Sumatriptan—Nausea—Lisinopril—coronary artery disease	1.5e-05	0.000107	CcSEcCtD
Sumatriptan—ABCB1—Metabolism—SLC9A1—coronary artery disease	2.93e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	2.93e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FN1—coronary artery disease	2.93e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—F2—coronary artery disease	2.93e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6ST—coronary artery disease	2.92e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	2.92e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EDN1—coronary artery disease	2.91e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.91e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AGT—coronary artery disease	2.9e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CETP—coronary artery disease	2.9e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCLC—coronary artery disease	2.9e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—coronary artery disease	2.9e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NFKBIA—coronary artery disease	2.89e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—coronary artery disease	2.89e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL5—coronary artery disease	2.89e-06	4.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SDC1—coronary artery disease	2.87e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KIT—coronary artery disease	2.86e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—coronary artery disease	2.86e-06	4.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB2—coronary artery disease	2.86e-06	4.11e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.85e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—coronary artery disease	2.84e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CSF2—coronary artery disease	2.84e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF1—coronary artery disease	2.84e-06	4.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LPL—coronary artery disease	2.82e-06	4.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCE—coronary artery disease	2.82e-06	4.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	2.82e-06	4.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS1—coronary artery disease	2.81e-06	4.05e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—coronary artery disease	2.81e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOA1—coronary artery disease	2.81e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—S100B—coronary artery disease	2.81e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KIT—coronary artery disease	2.8e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	2.8e-06	4.02e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SOCS3—coronary artery disease	2.78e-06	4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KITLG—coronary artery disease	2.75e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	2.75e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GSK3B—coronary artery disease	2.75e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	2.73e-06	3.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—coronary artery disease	2.72e-06	3.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CREB1—coronary artery disease	2.72e-06	3.92e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMB5—coronary artery disease	2.71e-06	3.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMA6—coronary artery disease	2.71e-06	3.9e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—coronary artery disease	2.69e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GSK3B—coronary artery disease	2.69e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP3—coronary artery disease	2.69e-06	3.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT5A—coronary artery disease	2.69e-06	3.86e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—coronary artery disease	2.68e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—coronary artery disease	2.68e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—coronary artery disease	2.67e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CREB1—coronary artery disease	2.67e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—coronary artery disease	2.67e-06	3.83e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	2.66e-06	3.83e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6R—coronary artery disease	2.66e-06	3.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	2.65e-06	3.81e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CTGF—coronary artery disease	2.65e-06	3.81e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—coronary artery disease	2.64e-06	3.79e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMGCR—coronary artery disease	2.62e-06	3.77e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT2—coronary artery disease	2.62e-06	3.77e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—coronary artery disease	2.62e-06	3.77e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—coronary artery disease	2.61e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK1—coronary artery disease	2.61e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—coronary artery disease	2.61e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6R—coronary artery disease	2.6e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	2.6e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOB—coronary artery disease	2.6e-06	3.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	2.57e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.57e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—coronary artery disease	2.57e-06	3.69e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—JAK2—coronary artery disease	2.56e-06	3.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EDN1—coronary artery disease	2.55e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK1—coronary artery disease	2.55e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	2.54e-06	3.66e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—coronary artery disease	2.54e-06	3.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL5—coronary artery disease	2.53e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CSF2—coronary artery disease	2.5e-06	3.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF1—coronary artery disease	2.5e-06	3.59e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—coronary artery disease	2.49e-06	3.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—coronary artery disease	2.49e-06	3.58e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—coronary artery disease	2.49e-06	3.58e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LPL—coronary artery disease	2.48e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—coronary artery disease	2.48e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—coronary artery disease	2.46e-06	3.54e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—coronary artery disease	2.46e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	2.46e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MEF2C—coronary artery disease	2.46e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—coronary artery disease	2.44e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.44e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—coronary artery disease	2.44e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	2.42e-06	3.48e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGT—coronary artery disease	2.41e-06	3.47e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLCB1—coronary artery disease	2.41e-06	3.47e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK1—coronary artery disease	2.41e-06	3.46e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF2—coronary artery disease	2.41e-06	3.46e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—coronary artery disease	2.41e-06	3.46e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ITGB3—coronary artery disease	2.39e-06	3.44e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—coronary artery disease	2.38e-06	3.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—coronary artery disease	2.37e-06	3.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—coronary artery disease	2.37e-06	3.4e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF2—coronary artery disease	2.36e-06	3.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOA1—coronary artery disease	2.34e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ABCA1—coronary artery disease	2.34e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	2.34e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—coronary artery disease	2.33e-06	3.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	2.33e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—coronary artery disease	2.32e-06	3.33e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JAK2—coronary artery disease	2.31e-06	3.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	2.3e-06	3.31e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—coronary artery disease	2.3e-06	3.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCD—coronary artery disease	2.28e-06	3.28e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—coronary artery disease	2.28e-06	3.28e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GGT1—coronary artery disease	2.26e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT1—coronary artery disease	2.26e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—coronary artery disease	2.26e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JAK2—coronary artery disease	2.26e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—coronary artery disease	2.26e-06	3.25e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—coronary artery disease	2.23e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—coronary artery disease	2.23e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—F2—coronary artery disease	2.23e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FN1—coronary artery disease	2.23e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—coronary artery disease	2.23e-06	3.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	2.22e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.22e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	2.2e-06	3.17e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIT—coronary artery disease	2.14e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—coronary artery disease	2.13e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—coronary artery disease	2.13e-06	3.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGT—coronary artery disease	2.12e-06	3.05e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—coronary artery disease	2.11e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—coronary artery disease	2.1e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—coronary artery disease	2.09e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—coronary artery disease	2.08e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—coronary artery disease	2.08e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	2.06e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOA1—coronary artery disease	2.05e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	2.05e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—coronary artery disease	2.04e-06	2.93e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—coronary artery disease	2.04e-06	2.93e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—coronary artery disease	2.03e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—coronary artery disease	2.03e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREB1—coronary artery disease	2.03e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK14—coronary artery disease	2.02e-06	2.91e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—coronary artery disease	2.02e-06	2.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.02e-06	2.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—coronary artery disease	2.01e-06	2.88e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—coronary artery disease	2e-06	2.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	1.99e-06	2.87e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—coronary artery disease	1.99e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—coronary artery disease	1.98e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6R—coronary artery disease	1.98e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—coronary artery disease	1.98e-06	2.85e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—coronary artery disease	1.98e-06	2.84e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—coronary artery disease	1.96e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—coronary artery disease	1.96e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—F2—coronary artery disease	1.96e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FN1—coronary artery disease	1.96e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—coronary artery disease	1.95e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6ST—coronary artery disease	1.95e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—coronary artery disease	1.95e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	1.95e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	1.94e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—coronary artery disease	1.92e-06	2.76e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOB—coronary artery disease	1.92e-06	2.76e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—coronary artery disease	1.91e-06	2.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIT—coronary artery disease	1.87e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—coronary artery disease	1.87e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—coronary artery disease	1.87e-06	2.68e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.86e-06	2.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	1.86e-06	2.67e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—coronary artery disease	1.85e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—coronary artery disease	1.85e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LPL—coronary artery disease	1.83e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	1.81e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GSK3B—coronary artery disease	1.8e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF2—coronary artery disease	1.8e-06	2.58e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—coronary artery disease	1.79e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—coronary artery disease	1.78e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREB1—coronary artery disease	1.78e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—coronary artery disease	1.77e-06	2.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—coronary artery disease	1.75e-06	2.51e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD36—coronary artery disease	1.74e-06	2.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6R—coronary artery disease	1.74e-06	2.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JAK2—coronary artery disease	1.72e-06	2.48e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.72e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.72e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	1.71e-06	2.46e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.71e-06	2.46e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—coronary artery disease	1.71e-06	2.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.69e-06	2.43e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	1.68e-06	2.41e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—coronary artery disease	1.65e-06	2.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.63e-06	2.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.63e-06	2.34e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.58e-06	2.27e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.57e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.57e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGT—coronary artery disease	1.57e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.56e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.54e-06	2.22e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.54e-06	2.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—coronary artery disease	1.54e-06	2.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOA1—coronary artery disease	1.52e-06	2.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.52e-06	2.18e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	1.51e-06	2.18e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.51e-06	2.17e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.51e-06	2.17e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.5e-06	2.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.5e-06	2.15e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.48e-06	2.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.46e-06	2.11e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	2.04e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—coronary artery disease	1.4e-06	2.02e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.38e-06	1.98e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.38e-06	1.98e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—coronary artery disease	1.34e-06	1.93e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.34e-06	1.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.33e-06	1.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.32e-06	1.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—coronary artery disease	1.32e-06	1.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.31e-06	1.89e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-06	1.88e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	1.29e-06	1.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.29e-06	1.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.28e-06	1.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.25e-06	1.8e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—coronary artery disease	1.24e-06	1.78e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.21e-06	1.74e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—coronary artery disease	1.2e-06	1.73e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.72e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—coronary artery disease	1.18e-06	1.7e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	1.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—coronary artery disease	1.16e-06	1.67e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—coronary artery disease	1.15e-06	1.66e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.15e-06	1.65e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—coronary artery disease	1.15e-06	1.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.12e-06	1.61e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.09e-06	1.57e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.07e-06	1.54e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—coronary artery disease	1.06e-06	1.52e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—coronary artery disease	1.05e-06	1.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.03e-06	1.48e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.01e-06	1.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.97e-07	1.43e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—coronary artery disease	9.8e-07	1.41e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.83e-07	1.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	8.76e-07	1.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—coronary artery disease	8.15e-07	1.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—coronary artery disease	7.75e-07	1.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—coronary artery disease	7.15e-07	1.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.48e-07	9.32e-06	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—coronary artery disease	5.3e-07	7.61e-06	CbGpPWpGaD
